What are the key takeaways from this The Biotech Startups Podcast episode?

Key insights include: **Acquisition negotiation posture:** When a buyer presents an offer, train yourself to respond with "I have no reaction — my responsibility is to take this to the board." Repeat this answer regardless of how many times they press. This removes emotional leverage from the buyer and prevents premature anchoring before board consultation, a tactic Patel used successfully against EMC's $25/share opening offer.; **Competitive leverage in M&A:** Actively build relationships with competing acquirers — NetApp, Dell, others — while in parallel OEM discussions. Patel scheduled a NetApp meeting the same day as EMC's Pat Gelsinger dinner, requiring a private jet to make both. Visible competition between buyers drove Isilon's price from an initial $25/share offer toward a final $33.85/share executed agreement.; **Talent acquisition speed:** When a high-value candidate becomes available, act within hours, not days. Patel called Leonard Ivan Tosh — a channels executive at rival NetApp — while he was still in the parking lot with his desk belongings. That same-day call led to an immediate hire who rebuilt Isilon's indirect distribution program before the EMC acquisition closed.

What did Sujal Patel discuss on The Biotech Startups Podcast?

Sujal Patel recounts the high-stakes acquisition of Isilon by EMC, detailing months of OEM pretense negotiations, a Saturday phone negotiation that landed at $33.85 per share, post-acquisition leadership decisions that preserved $25 billion in lifetime revenue, and the founding of Nautilus Biotechnology with co-founder Parag Malik in 2016. Key topics include: **Acquisition negotiation posture:** When a buyer presents an offer, train yourself to respond with "I have no reaction — my responsibility is to take this to the board." Repeat this answer regardless of how many times they press. This removes emotional leverage from the buyer and prevents premature anchoring before board consultation, a tactic Patel used successfully against EMC's $25/share opening offer.; **Competitive leverage in M&A:** Actively build relationships with competing acquirers — NetApp, Dell, others — while in parallel OEM discussions. Patel scheduled a NetApp meeting the same day as EMC's Pat Gelsinger dinner, requiring a private jet to make both. Visible competition between buyers drove Isilon's price from an initial $25/share offer toward a final $33.85/share executed agreement..

How long is this episode of The Biotech Startups Podcast?

This episode is 35 minutes long. SignalCast provides an AI-generated summary so you can get the key insights in about 3 minutes.

The Biotech Startups Podcast

🧬 "Be On It”: High-Stakes Deals & Building World-Class Teams | Sujal Patel (Part 3/4)

March 9, 2026

35 min episode · 2 min read

Sujal Patel

Episode

35 min

Read time

2 min

Topics

Relationships, Investing, Startups

AI-Generated Summary

Published Mar 16, 2026

Key Takeaways

✓Acquisition negotiation posture: When a buyer presents an offer, train yourself to respond with "I have no reaction — my responsibility is to take this to the board." Repeat this answer regardless of how many times they press. This removes emotional leverage from the buyer and prevents premature anchoring before board consultation, a tactic Patel used successfully against EMC's $25/share opening offer.
✓Competitive leverage in M&A: Actively build relationships with competing acquirers — NetApp, Dell, others — while in parallel OEM discussions. Patel scheduled a NetApp meeting the same day as EMC's Pat Gelsinger dinner, requiring a private jet to make both. Visible competition between buyers drove Isilon's price from an initial $25/share offer toward a final $33.85/share executed agreement.
✓Talent acquisition speed: When a high-value candidate becomes available, act within hours, not days. Patel called Leonard Ivan Tosh — a channels executive at rival NetApp — while he was still in the parking lot with his desk belongings. That same-day call led to an immediate hire who rebuilt Isilon's indirect distribution program before the EMC acquisition closed.
✓Expanded product-market fit framework: Traditional product-market fit covers roughly 33% of what startups need. The remaining 66% involves whether you can manufacture at scale, sell cost-effectively, shorten sales cycles, and defend against competitive displacement. Patel applied this lens to 80 private investments and used it to narrow Isilon's go-to-market from seven verticals to five before expanding to general purpose.
✓Post-acquisition structural preservation: Before signing, negotiate reporting structure and operational independence explicitly. Patel refused to report to the acquiring division head, escalated directly to Pat Gelsinger, and ultimately convinced EMC CEO Joe Tucci to keep Isilon as a standalone unit rather than merging it. That decision protected the product line, which has since generated over $25 billion in lifetime revenue inside Dell.

What It Covers

Sujal Patel recounts the high-stakes acquisition of Isilon by EMC, detailing months of OEM pretense negotiations, a Saturday phone negotiation that landed at $33.85 per share, post-acquisition leadership decisions that preserved $25 billion in lifetime revenue, and the founding of Nautilus Biotechnology with co-founder Parag Malik in 2016.

Key Questions Answered

•Acquisition negotiation posture: When a buyer presents an offer, train yourself to respond with "I have no reaction — my responsibility is to take this to the board." Repeat this answer regardless of how many times they press. This removes emotional leverage from the buyer and prevents premature anchoring before board consultation, a tactic Patel used successfully against EMC's $25/share opening offer.
•Competitive leverage in M&A: Actively build relationships with competing acquirers — NetApp, Dell, others — while in parallel OEM discussions. Patel scheduled a NetApp meeting the same day as EMC's Pat Gelsinger dinner, requiring a private jet to make both. Visible competition between buyers drove Isilon's price from an initial $25/share offer toward a final $33.85/share executed agreement.
•Talent acquisition speed: When a high-value candidate becomes available, act within hours, not days. Patel called Leonard Ivan Tosh — a channels executive at rival NetApp — while he was still in the parking lot with his desk belongings. That same-day call led to an immediate hire who rebuilt Isilon's indirect distribution program before the EMC acquisition closed.
•Expanded product-market fit framework: Traditional product-market fit covers roughly 33% of what startups need. The remaining 66% involves whether you can manufacture at scale, sell cost-effectively, shorten sales cycles, and defend against competitive displacement. Patel applied this lens to 80 private investments and used it to narrow Isilon's go-to-market from seven verticals to five before expanding to general purpose.
•Post-acquisition structural preservation: Before signing, negotiate reporting structure and operational independence explicitly. Patel refused to report to the acquiring division head, escalated directly to Pat Gelsinger, and ultimately convinced EMC CEO Joe Tucci to keep Isilon as a standalone unit rather than merging it. That decision protected the product line, which has since generated over $25 billion in lifetime revenue inside Dell.

Notable Moment

After EMC walked away from the deal at $32.50/share on a Friday afternoon, Patel rejected the fully executed merger agreement sent by fax. The following Saturday, during a tight phone negotiation, he requested $34, was told that specific number was off-limits, and landed on $33.85 — a $5 million difference in total consideration.

Know someone who'd find this useful?

Episode Transcript

This episode is brought to you by Xcedar. Xcedar provides life science startups with equipment leases on founder friendly terms to accelerate r and d and commercialization. Lease the equipment you need with Xcedar. Extend your runway, hit your milestones, raise your next round at a favorable valuation, and achieve a blockbuster exit while minimizing dilution. Additionally, as a podcast listener, you can redeem exclusive discounts with a growing list of biotech vendors and get $500 off your first equipment lease by using promo code t b s p on exceda.com/partners. Welcome to the biotech startups podcast by Xida. Join us as we speak with first time founders, serial entrepreneurs, and experienced investors about the challenges and triumphs of running a biotech startup from pre seed to IPO with your host, John Chi. In our last episode, Soojil shared identifying the storage problem with real networks, the scissors of opportunity moment with Paul Maxwell, and raising $8,400,000 as Seattle's only series a in 2001. If you missed it, check out part two. In part three, Suzhou talks about EMC leaving a voicemail on the company's general line, months of OEM discussions that were really acquisition pretense, and Pat Gelsinger bringing Harry Yoo, the head of m and a, to what was supposed to be an operationalization meeting. He shares how EMC walked away at $32.5 per share, why he told them the next time we meet, the price could be a $100, and receiving a fully executed merger agreement by fax at 01:05PM, executed merger agreement by fax at 01:05PM on a Friday. He also shares the Saturday negotiation where he asked for $34. Harry Yu said you can name your number, but it cannot be $34. And why $33.85 representing $5,000,000 in consideration became the final price. Oh, man. And talk about a little bit about that acquisition. Like, how did that come to fruition? How much detail do you want? Yeah. You know, as much as you're willing to give. It's a really fun process. I can give you quite a bit because, you know, we're both public companies, and so our proxy is pretty detailed. And so I'm gonna give it to you from two angles. Right? Because remember, I was then acquired by EMC, so I was privy to all the documents they wrote at the time that these things occurred back in time. And so sometime in April, like, our stock's at $12. And internally, the EMC deck is like, this is a great target that we should go acquire. Stocks up from two to five to 12. So it's really run up, and it's kinda crazy price, but we should look at this. And the MC is a company that is a very old company. I don't remember. It was founded in the seventies, I think. And it's based in Hopkinton, Massachusetts, in the suburbs of Boston. Very old school New England. They all sound like they're out of the godfather, and their style …

Get the full transcript (7,046 words) + summary by email — free

One-time email with the complete transcript and AI summary of this episode. No account needed.

One email, no spam. We’ll also show you what SignalCast does.

Browse all The Biotech Startups Podcast transcripts →